Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Beclomethasone to Prevent Chronic Lung Disease
NCT00000576Phase 3Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1993
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of beclomethasone in bronchopulmonary dysplasia (BPD), sponsored by National Heart, Lung, and Blood Institute. Started Jun 1993; status: completed.
02
Drugs
beclomethasone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT00000576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000576.